Skip to main content

EhBuddy Peptides

Survodutide

$121.00

EhBuddy Research-Grade Survodutide

Survodutide (BI 456906) is an investigational dual GLP-1/glucagon receptor agonist in Phase 3 trials for obesity and NASH. Research data from the LIGHT UP trials demonstrates substantial body weight reduction along with significant improvements in liver histology — making it one of the most promising compounds in NASH research alongside metabolic syndrome.

Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.

FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.

Free shipping on Canadian orders over $350

On Backorder — Estimated dispatch within 8 business days for most backorders. Shipping notification sent by email once dispatched.

Available on backorder

Description

Survodutide — Dual GLP-1/Glucagon Receptor Agonist for NASH & Obesity Research

Survodutide (BI 456906), developed by Boehringer Ingelheim, is a dual GLP-1 and glucagon receptor co-agonist demonstrating exceptional potential in both obesity and NASH research. While sharing a dual-agonist mechanism with Mazdutide, Survodutide’s unique molecular design and glucagon potency profile has generated compelling data in metabolic liver disease — an underserved area of research.


Reconstitution: Reconstitute with Bacteriostatic Water (BAC Water) for multi-use stability, or Sterile Water for single-use protocols. Store lyophilized vials at 2–8°C.

Key Research Areas

⚡ Obesity & Weight Loss

Phase 2 data shows dose-dependent weight reduction of up to 19% over 46 weeks, placing Survodutide among the most effective compounds in the dual-agonist class. Phase 3 LIGHT UP trial is ongoing for obesity.

🧬 NASH Research — Leading Compound

Phase 2 LIGHT ON trial demonstrated 69% NASH resolution rate at highest dose — significantly exceeding placebo. Survodutide’s glucagon receptor activity drives hepatic lipid oxidation and reduces steatosis, fibrosis, and liver enzyme markers in NASH models.

🔥 Metabolic Syndrome

Research models show improvements in multiple metabolic syndrome components simultaneously: visceral adiposity, insulin resistance, dyslipidaemia, and hypertension — relevant across cardiovascular-metabolic research.

❤️ Cardiovascular Research

Early data suggests beneficial effects on cardiovascular risk markers consistent with GLP-1 class compounds, with ongoing research in the LIGHT WEIGHT cardiovascular outcomes trial.


Why Choose EhBuddy?

  • Verified Purity — Third-party tested for identity and potency
  • Fast Canadian Shipping — Discreet packaging, shipped from Canada
  • Research-Grade Quality — Strict manufacturing quality standards

FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.

Additional information
Weight 0.05 lbs
🔬 Research Notes

⚗️ For Research Use Only. All products are intended strictly for laboratory and scientific research. Not for human or veterinary consumption.

GLP-1 receptor agonists are studied in metabolic research for glucose-dependent insulin secretion, glucagon suppression, gastric emptying modulation, and hypothalamic appetite regulation. Multi-receptor agonist compounds (GLP-1/GIP/glucagon) are an active research area for additive effects on energy expenditure and adipose tissue reduction.

COA

View the Certificate of Analysis (HPLC) for this product. All testing is now performed by PeakPurePeps — a local, Canadian-owned lab. If a COA for your selected batch isn’t posted yet, testing is in progress or we’re awaiting our next restock.

View this product’s COA ›
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Survodutide”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

Shipping & Delivery Information

Free Shipping on all orders over $350 CAD. Orders under $350 CAD are subject to a flat shipping fee.

Carriers: We ship via Canada Post Xpresspost and other couriers to ensure reliable delivery across Canada.

Estimated Delivery Times:

  • Ontario & Quebec: 1–3 business days
  • Western Canada (BC, AB, SK, MB): 2–5 business days
  • Atlantic Canada: 3–5 business days
  • Northern Territories: 5–10 business days

Packaging: All orders ship in discreet, unmarked packaging. No product names or company branding appear on the exterior.

Tracking: A tracking number will be emailed once your order ships. Most orders ship within 1 business day of payment confirmation.

Temperature-Sensitive Items: Lyophilized (freeze-dried) peptides are stable at room temperature for shipping. Store at 2–8°C upon receipt for long-term stability.

Questions? Contact us at Contact@EhBuddyPeptides.io

Disclaimer

You must be 18 or 19 years of age depending on the age of majority in your province and a licensed research professional.

All products — including research peptides and research compounds — are sold strictly for laboratory and scientific research purposes only. Not for human or veterinary consumption. No dosing instructions are provided.

We adhere to all provincial and federal laws in Canada governing Research Only Chemical sales.

By clicking "I Agree" you confirm you have read and accepted the Terms and Conditions above.